Tumor‐Necrosis Factor and other Cytokines in Cerebral Malaria: Experimental and Clinical Data

Immunological Reviews

Volumn 112, Issue 1, 1989, Pages 49-70

  Grau, Georges E ^a   Piguet, Pierre‐FranClois ^a   Vassalli, Pierre ^a   Lambert, Paul‐Henri ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 3; TUMOR NECROSIS FACTOR; BIOLOGICAL FACTOR;

BRAIN MALARIA; CHICKEN; HELPER CELL; HUMAN; IMMUNIZATION; MALARIA; PRIORITY JOURNAL; PROTOZOON; REVIEW; ANIMAL; BRAIN DISEASE; DISEASE MODEL; IMMUNOLOGY; MOUSE; T LYMPHOCYTE;

ANIMAL; BIOLOGICAL FACTORS; BRAIN DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; HUMAN; MALARIA; MICE; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0024854758     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1989.tb00552.x     Document Type: Article

References (77)

1. Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria
2. Characterization of receptors for human tumour necrosis factor and their regulation by gamma‐interferon
3. Pathology of malaria
4. Cachectin: more than a tumor necrosis factor
5. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin
6. Platelet‐activating factor and cellular immune responses
7. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize platelet‐activating factor
8. Brain injury, edema, and permeability changes induced by oxygen‐derived free radicals
9. Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis
10. Correlation between susceptibihty to malaria and babesia parasites and to endotoxicity
11. Suggested importance of monokines in pathophysiology of endotoxin shock and malaria
12. Monokines and lymphokines in malarial pathology
13. Cell‐mediated immunity in protection and pathology of malaria
14. Some roles of free radicals in malaria
15. Possible roles of tumor necrosis factor in the pathology of malaria
16. Inhibition of murine malaria (P. chabaudi) in vivo by recombinant interferon gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole
17. Possible importance of macrophage‐derived mediators in acute malaria
18. Ultrastructure of the lung in falciparum malaria
19. Cerebral malaria in the Gold Coast African: four autopsy reports
20. Pathology of malaria in West Africa
21. Platelet‐activating factor and shock
22. Virulent R berghei malaria: prolonged survival and decreased cerebral pathology in T cell‐deficient nude mice
23. Tumor necrosis factor and interleukin 1 in the serum of children with infectious purpura
24. Host immune response and pathological expression in malaria: possible implications for malaria vaccines
25. Tumor necrosis factor/cachectin as an essential mediator in murine cerebral malaria
26. Prevention of murine cerebral malaria by low‐dose cyclosporin
27. Monoclonal anti‐gamma interferon antibodies prevent experimental cerebral malaria and its TNF overproduction
28. Prevention of experimental cerebral malaria by anti‐cytokine antibodies. Interleukin 3 and granulocyte‐macrophage colony‐stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation
29. + T lymphocytes play a major role in the pathogenesis of murine cerebral malaria
30. Tumor necrosis factor and disease severity in children with falciparum malaria
31. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa
32. Quartan malarial nephrotic syndrome
33. A multifunctional cytokine (IL‐6/BSF‐2) and its receptor
34. Lipoprotein lipase suppression in 3T3‐L1 cells by a haemoprotozoan‐induced mediator from peritoneal exudate cells
35. Immunopathological mechanisms in protozoal infections
36. Malarial proteins at the membrane of Plasmodium falciparum‐ infected erythrocytes and their involvement in cytoadherence to endothelial cells
37. The immunological response of CBA mice to P. yoelii. I. General characteristics, the effects of T cell deprivation and reconstitution with thymus grafts
38. Both monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen presenting cells in the activation of T cells
39. Tumor necrosis factor and Interleukin 1: Cytokines with multiple overlapping biological activities
40. Do patients with cerebral malaria have cerebral oedema? A computed tomography study
41. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocytes sequestration
42. The pathogenesis of mammahan malaria
43. Other pathological processes in malaria
44. Immunopathology of malaria
45. Cell‐mediated immunity in protein calorie malnutrition. Prog.
46. Detection of circulating tumor necrosis factor after endotoxin administration
47. The malaria situation in 1976
48. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor
49. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum‐infected children
50. Human cerebral malaria: A pathological study
51. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma‐interferon and interleukin‐1
52. The pathophysiology of severe falciparum malaria
53. Tumor necrosis factor/cachectin plays a key role in bleomycin‐induced pneumopathy and fibrosis
54. Tumor necrosis factor is an effector of skin and gut lesions of the acute phase of graft‐versus‐host disease
55. Pneumopathies of the Graft‐versus‐Host reaction
56. Cytokine‐mediated activation of vascular endothelium. Physiology and pathology
57. The interferon compartment of the immune response in malaria. II. Presence of serum interferon gamma following the acute attack
58. Comparative analysis of the Plasmodium falciparum histidine‐rich proteins HRP‐I, HRP‐II and HRP‐III in malaria parasites of diverse origin
59. Raised serum levels of tumor necrosis factor in parasitic infections
60. Thrombospondin binding by parasitized erythrocyte isolates in falciparum malaria
61. Toxicity of tumor necrosis factor is synergistic with gamma interferon and can be reduced with cyclooxygenase inhibitors
62. Macrophage cytoxicity in lethal and non‐lethal malaria and the effect of vaccination
63. Glycemic status of Malawian children with severe flaciparum malaria before and during administration of intravenous quinine
64. Factors contributing to the development of cerebral malaria. 1. Humoral immune responses
65. Purification and NH2‐terinal amino acid sequence of a T‐cell derived lymphokine with growth factor activity for B‐cell hydridomas. Proc. Natl. Acad. Sci.
66. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro
67. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease
68. Immunopathology of renal complications in simian malaria and human quartan malaria
69. Function of the blood‐cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis
70. Pathophysiology of severe falciparum malaria in man
71. The acute metabolic effects of tumor necrosis factor administration in humans
72. Malaria and alterations in immune reactivity
73. Malaria pathophysiology
74. Severe and complicated malaria
75. Lymphocyte transformation in human Plasmodium falciparum malaria
76. Peripheral lymphocyte subpopulations in human falciparum malaria